An Address From Dr. Richard Pazdur: How the Changing Landscape of Oncology Drug Development and Approval Will Affect Advanced Practice
Richard Pazdur, MD
US Food and Drug Administration
Get an inside perspective on how the FDA updates its drug approval processes to reflect the changing oncology treatment environment and to incorporate the voice of the patient. With increasing numbers of oncology drug approvals and the ever-important area of molecularly targeted therapy, it is critical that advanced practitioners embrace and support this change.
These CME/CE/CPE accredited activities are jointly provided by